|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/20 | |
| A61K 31/485 | |||
| C07D 489/08 |
| (11) | Number of the document | 2371357 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11157837.3 |
| Date of filing the European patent application | 2011-03-11 | |
| (97) | Date of publication of the European application | 2011-10-05 |
| (45) | Date of publication and mention of the grant of the patent | 2017-02-01 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 313018 P | 2010-03-11 | US |
| (72) |
Shah, Syed M., US
Diorio, Christopher Richard, US
Ehrnsperger, Eric C., US
Meng, Xu, US
Shareffi, Kadum A., US
Cohen, Jonathan Marc, US
|
| (73) |
Wyeth LLC,
235 East 42nd Street, New York, NY 10017,
US
|
| (54) | Oral formulations and lipophilic salts of methylnaltrexone |
| Oral formulations and lipophilic salts of methylnaltrexone |